产品名称 | Homocamptothecin, (±)-E- - hCPT, dl- | BN 80245 |
产品货号 | Axon 1687 CAS [186668-40-6] MF C21H18N2O4MW 362.38 Purity: 99% Optical purity: racemate Moderately soluble in DMSO Description A potent topoisomerase I (Topo 1) inhibitor; Homocamptothecin (hCPT) is an E-ring modified analogue of camptothecin (CPT), with enhanced stability and potent Topo-1 mediated activity; apoptosis agent References Certificates Categories Extra info L Lesueur-Ginot et al. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. Cancer Res. 1999, 59(12), 2939-2943. O Lavergne et al. Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues. J. Med. Chem. 1998, 41(27), 5410–5419. Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Signaling & Oncology DNA-damage Response EC 5.99.1.2 TOPO Potent topoisomerase I (Topo 1) inhibitor Chemical name 3H,15H-Oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy- Parent CAS No. [186668-40-6] Order Size Unit Price Stock 5 mg €135.00 In Stock |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | |
产品品牌 | axonmedchem |
产品概述 | |
产品详情 |
Homocamptothecin, (±)-E- - hCPT, dl- | BN 80245Axon 1687 CAS [186668-40-6] MF C21H18N2O4
Description
A potent topoisomerase I (Topo 1) inhibitor; Homocamptothecin (hCPT) is an E-ring modified analogue of camptothecin (CPT), with enhanced stability and potent Topo-1 mediated activity; apoptosis agent
Potent topoisomerase I (Topo 1) inhibitor
Chemical name3H,15H-Oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy- Parent CAS No.[186668-40-6] |
产品资料 |